Addressing Cardiometabolic Risks Among Clients Screened for Substance Use Disorders and Type 2 Diabetes
Sub-Saharan Africa, particularly Nigeria, is facing a critical situation- the highest number of people with undiagnosed Type 2 Diabetes (T2D) and a rapidly rising prevalence of substance use disorder (SUD). This trend demands immediate attention and action. Co-occurrence of SUD and T2D can lead to adverse health effects, including cardiovascular disease (CVD). Family history of T2D and/or CVD is a non-modifiable cardiometabolic risk factor, while increased body mass index (BMI), substance use, decreased physical activity, poor dietary habits, uncontrolled glucose levels, and dyslipidemia are modifiable risk factors. Nurses are not just called to action; they are empowered to address modifiable cardiometabolic risks through integrated care management.
Presenters
Oluremi A. Adejumo, DNP, MS, RN, FIAAN, CGNC
Dr. Adejumo works on promoting equitable access to preventive health care services in the United States and abroad. Integration of evidence-based preventive care is vital to individuals in substance abuse treatment, considering their ongoing physical and sociolo-economic issues leading to their shorter lifespan. Knowledge-sharing best practices can enhance health promotion and help bridge the gaps in prevention. Thus, moving from the silos, she participates in interdisciplinary, evidence-based preventive health practice to promote quality health outcomes in at risk populations.
Elizabeth O. Ogunbiyi, MPH, BSc Nursing, DAC, RPN, RN, RM.
Mrs. Elizabeth Olamide Ogunbiyi is the Deputy Director of Nursing. Head of unit- Outpatient Behavioral Science Clinic for psychiatric and SUD treatments at the University of Ilorin Teaching Hospital Ilorin, Kwara State, Nigeria.
Learning Objectives
- Explain the public health impact of co-morbid substance use disorders (SUD) and Type 2 Diabetes (T2D).
- Discuss the link between SUD, T2D, and other cardiometabolic-risk factors.
- List the behavioral and physical consequences of co-occurring SUD and T2D.
- Identify at least two nursing implications relating to co-occurring SUD and T2D.
- Apply information using an exemplary pilot study’s discussion.
